OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Safety of Upadacitinib in Immune-Mediated Inflammatory Diseases: Systematic Literature Review of Indirect and Direct Treatment Comparisons of Randomized Controlled Trials
Eduardo Mysler, Gerd R Burmester, Christopher D. Saffore, et al.
Advances in Therapy (2024) Vol. 41, Iss. 2, pp. 567-597
Open Access | Times Cited: 9
Eduardo Mysler, Gerd R Burmester, Christopher D. Saffore, et al.
Advances in Therapy (2024) Vol. 41, Iss. 2, pp. 567-597
Open Access | Times Cited: 9
Showing 9 citing articles:
Biologics Versus JAK Inhibitors. Part II: Risk of Infections. A Narrative Review
Miguel Mansilla‐Polo, D. Morgado‐Carrasco
Dermatology and Therapy (2024) Vol. 14, Iss. 8, pp. 1983-2038
Open Access | Times Cited: 8
Miguel Mansilla‐Polo, D. Morgado‐Carrasco
Dermatology and Therapy (2024) Vol. 14, Iss. 8, pp. 1983-2038
Open Access | Times Cited: 8
Disease clearance in ulcerative colitis: A new therapeutic target for the future
Syed Adeel Hassan, Neeraj Kapur, Fahad Sheikh, et al.
World Journal of Gastroenterology (2024) Vol. 30, Iss. 13, pp. 1801-1809
Open Access | Times Cited: 5
Syed Adeel Hassan, Neeraj Kapur, Fahad Sheikh, et al.
World Journal of Gastroenterology (2024) Vol. 30, Iss. 13, pp. 1801-1809
Open Access | Times Cited: 5
Upadacitinib for difficult‐to‐treat paediatric Crohn's disease
Natalia Nedelkopoulou, Shishu Sharma, Muhammad Khalid, et al.
JPGN Reports (2025)
Open Access
Natalia Nedelkopoulou, Shishu Sharma, Muhammad Khalid, et al.
JPGN Reports (2025)
Open Access
Janus kinase inhibitors for psoriatic arthritis: Evidence from a systematic review and network meta-analysis
Sotirios G. Tsiogkas, Arriana Gkouvi, Katerina‐Maria Kontouli, et al.
Autoimmunity Reviews (2025), pp. 103819-103819
Open Access
Sotirios G. Tsiogkas, Arriana Gkouvi, Katerina‐Maria Kontouli, et al.
Autoimmunity Reviews (2025), pp. 103819-103819
Open Access
U-ACTIVATE long-term efficacy and safety outcomes for upadacitinib in ulcerative colitis
Nurulamin M Noor, Miles Parkes, Tim Raine
The Lancet. Gastroenterology & hepatology (2025) Vol. 10, Iss. 6, pp. 492-493
Closed Access
Nurulamin M Noor, Miles Parkes, Tim Raine
The Lancet. Gastroenterology & hepatology (2025) Vol. 10, Iss. 6, pp. 492-493
Closed Access
Biologics Versus JAK Inhibitors. Part I: Cancer Risk. A Narrative Review
Miguel Mansilla‐Polo, D. Morgado‐Carrasco
Dermatology and Therapy (2024) Vol. 14, Iss. 6, pp. 1389-1442
Open Access | Times Cited: 3
Miguel Mansilla‐Polo, D. Morgado‐Carrasco
Dermatology and Therapy (2024) Vol. 14, Iss. 6, pp. 1389-1442
Open Access | Times Cited: 3
Comparative Efficacy of Advanced Therapies in the Treatment of Radiographic Axial Spondyloarthritis or Ankylosing Spondylitis as Evaluated by the ASDAS Low Disease Activity Criteria
Xenofon Baraliakos, Christopher D. Saffore, Eric B. Collins, et al.
Rheumatology and Therapy (2024) Vol. 11, Iss. 4, pp. 989-999
Open Access | Times Cited: 1
Xenofon Baraliakos, Christopher D. Saffore, Eric B. Collins, et al.
Rheumatology and Therapy (2024) Vol. 11, Iss. 4, pp. 989-999
Open Access | Times Cited: 1
Game changer: How Janus kinase inhibitors are reshaping the landscape of ulcerative colitis management
Antonio M.� Caballero-Mateos, Guillermo A. Cañadas‐De la Fuente
World Journal of Gastroenterology (2024) Vol. 30, Iss. 35, pp. 3942-3953
Closed Access | Times Cited: 1
Antonio M.� Caballero-Mateos, Guillermo A. Cañadas‐De la Fuente
World Journal of Gastroenterology (2024) Vol. 30, Iss. 35, pp. 3942-3953
Closed Access | Times Cited: 1
A systematic review and meta-analysis of the efficacy and safety of iguratimod in the treatment of inflammatory arthritis and degenerative arthritis
Zhiyong Long, Liuting Zeng, Kailin Yang, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 1
Zhiyong Long, Liuting Zeng, Kailin Yang, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 1
Treatment of Autoimmune Rheumatic Disease and the Risk of Malignancy
Ziga Vodusek, Clifton O Bingham, Christopher A. Mecoli
Current Treatment Options in Rheumatology (2024) Vol. 10, Iss. 4, pp. 61-76
Closed Access
Ziga Vodusek, Clifton O Bingham, Christopher A. Mecoli
Current Treatment Options in Rheumatology (2024) Vol. 10, Iss. 4, pp. 61-76
Closed Access
